How Can I Shrink My Thyroid Nodules Without Surgery?

Several non-surgical treatments can meaningfully shrink thyroid nodules, with the strongest results coming from image-guided ablation techniques that destroy nodule tissue using heat or alcohol injected through a needle. Radiofrequency ablation, the most studied of these methods, reduces nodule volume by roughly 80% within a year in most patients. But before exploring what can shrink a nodule, the more important question for many people is whether their nodule needs shrinking at all.

Most Benign Nodules Do Not Need Treatment

The majority of thyroid nodules are benign, and most of those stay stable or grow so slowly that they never cause problems. Current guidelines recommend periodic ultrasound monitoring rather than immediate intervention for confirmed benign nodules.¹ A long-term study tracking nearly 400 benign nodules over an average of about eight years found that roughly half were essentially stagnant, growing less than 0.2 mm per year. Another third grew slowly, and only about one in six was considered fast-growing at over 1 mm per year. Even among the fast growers, the vast majority remained benign on repeat biopsy, and only a small fraction ultimately needed surgical removal.²

This matters because once you know your nodule is benign, the decision to pursue treatment is almost always about symptoms or cosmetic concerns, not cancer risk. If your nodule is not causing a lump in your throat, difficulty swallowing, pressure, or a visible bulge, there may be nothing to gain from shrinking it. That said, for people who do have symptoms, or who are anxious about a growing nodule, the options below are worth discussing with an endocrinologist.

Radiofrequency Ablation

Radiofrequency ablation (RFA) has become the most widely studied and practiced non-surgical method for shrinking solid benign thyroid nodules. The procedure involves inserting a thin electrode through the skin under ultrasound guidance and delivering heat energy directly into the nodule, destroying the tissue from within. It is typically done as an outpatient procedure under local anesthesia.

The volume reductions are substantial. A large prospective multicenter study of 276 nodules reported an average volume reduction of about 80% at one year, climbing to roughly 90% by three years.³ Another study of 236 patients found a mean volume reduction of about 84%, with more than a quarter of treated nodules essentially disappearing on follow-up imaging.⁴ A U.S. study showed that along with shrinkage, patients experienced significant improvements in goiter symptoms, cosmetic concerns, and anxiety within three months, with quality-of-life gains persisting through a year of follow-up.⁵

The complication rate is low. In the multicenter study, the overall complication rate was about 5%, and almost all complications were minor, such as temporary pain or small bruises. Only one patient out of 276 had a lasting side effect that required medication.³

There is one caveat worth knowing about. While the initial shrinkage tends to hold, some nodules begin to regrow after a few years, usually at the margins where tissue was not fully destroyed during the initial session. A five-year Italian study found regrowth in about 20% of RFA-treated patients, though only 12% needed a second treatment.⁶ Another five-year follow-up found that about 23% of nodules regrew and 12% were retreated, but overall the shrinkage was maintained for most patients.⁷ One important predictor: treating a higher proportion of the nodule’s volume in the first session reduces the chance of regrowth later.

Before you can get RFA, guidelines recommend that benign status be confirmed by at least two separate fine-needle aspiration biopsies.⁸ This double-check is a safety measure to avoid inadvertently ablating a nodule that turns out to be cancerous.

Laser Ablation and Microwave Ablation

RFA is not the only thermal ablation option. Laser ablation uses thin optical fibers inserted into the nodule to deliver targeted heat. It has been described as the least invasive of the thermal techniques because it uses the smallest applicators available.⁹ A ten-year follow-up study of 171 patients found a volume reduction of about 68% at one year, sustained at 59% even after a decade. Regrowth was uncommon in the first few years, though a small percentage of patients did see regrowth after four to seven years. Treatment was well tolerated, with only minor side effects like temporary pain and mild fever, and 98% of patients said they would recommend it.¹⁰

One trade-off compared with RFA: the five-year Italian study that compared the two directly found that laser-treated nodules had a higher regrowth rate (38% versus 20% for RFA) and a higher retreatment rate (24% versus 12%).⁶ Both techniques are effective, but RFA appears to have a somewhat more durable result.

Microwave ablation is a newer entrant. Early studies report volume reductions in the range of 46% to 65%, with about a quarter of nodules disappearing entirely at twelve months in one study.¹¹ A systematic review and meta-analysis found significant improvements in nodule volume and symptom scores, with the most common adverse effects being bruising, pain, and temporary voice changes in a small percentage of patients.¹² The evidence base is smaller than for RFA, but the results are promising.

High-Intensity Focused Ultrasound

High-intensity focused ultrasound (HIFU) stands apart from the other ablation methods because it does not require any needles at all. Energy is delivered from outside the body and focused on the nodule, making it the only truly non-invasive thermal option.¹³ That sounds ideal on paper, but the results so far are more modest than those of needle-based ablation. A multicenter study following patients for three years found a median volume reduction of about 32% at both one year and three years.¹⁴ Another study reported a somewhat better average reduction of about 48% at one year.¹⁵ Either way, that is roughly half the shrinkage you would expect from RFA. HIFU is a reasonable option for someone who strongly wants to avoid any needle insertion, but for most patients, a needle-based method will deliver a bigger volume reduction.

Ethanol Ablation for Cystic Nodules

If your nodule is mostly fluid-filled rather than solid, you have a different and particularly effective option. Ethanol ablation (also called percutaneous ethanol injection) involves draining the cyst and injecting a small amount of alcohol, which destroys the cyst lining and prevents the fluid from reaccumulating. For purely cystic nodules, volume reductions of 80% to 100% are reported. For predominantly cystic nodules that still have a solid component, reductions tend to be in the range of 65% to 85%.¹⁶

A comparative study found that for predominantly cystic nodules, ethanol ablation achieved results similar to RFA in terms of volume reduction, symptom relief, and cosmetic improvement, but required fewer treatment sessions and is cheaper and simpler to perform. The authors concluded that ethanol ablation should be the first-line treatment for this type of nodule.¹⁷ A review echoed that conclusion, noting the low risk and impressive results.¹⁸ The key point: ethanol ablation works best when there is a significant fluid component. It is not typically used for solid nodules, where thermal ablation is more appropriate.

Radioactive Iodine

Radioactive iodine therapy has been used for decades to treat toxic nodular goiter, where one or more nodules overproduce thyroid hormone. If your nodules are causing hyperthyroidism, this is often the treatment of choice. The radioactive iodine is taken up by the overactive thyroid tissue and gradually destroys it. A review of the evidence found that this approach leads to a goiter volume reduction of roughly 35% to 50% within one to two years.¹⁹ One study of non-toxic multinodular goiter showed even larger reductions, with total thyroid volume shrinking by nearly 78% and individual nodule volumes dropping by 35% to 41%.²⁰

Radioactive iodine is not typically used for a single small benign nodule that is not producing excess hormone. Its main role is in managing thyroid overactivity or large goiters that are causing compressive symptoms, particularly when a patient cannot undergo surgery. One significant downside is that it frequently leads to hypothyroidism, meaning you may need lifelong thyroid hormone replacement afterward.

Levothyroxine Suppression Therapy

Taking levothyroxine (synthetic thyroid hormone) at doses high enough to suppress TSH was once a common strategy to shrink benign nodules. The idea is that by turning down the signal telling the thyroid to grow, nodule tissue might gradually shrink. The evidence for this approach is mixed. A French randomized trial found that suppressive levothyroxine therapy did reduce nodule volume, with about 27% of treated patients achieving a clinically meaningful 50% shrinkage compared with about 17% on placebo.²¹ However, a smaller study found no meaningful change in nodule size after six months compared with a control group.²²

Even when suppression therapy works, the effect tends to be modest, and it comes with real risks. Keeping TSH artificially low can cause bone loss and heart rhythm problems, particularly in older adults. Most current guidelines do not recommend routine TSH suppression for benign nodules, reserving it for selected patients who are carefully monitored.

Metformin for Patients With Insulin Resistance

An interesting finding has emerged for people who have both thyroid nodules and insulin resistance. Insulin resistance and elevated insulin levels appear to promote thyroid cell growth, and metformin, the widely prescribed diabetes medication, may counteract this. Two separate meta-analyses have found small but statistically significant reductions in thyroid nodule size after metformin treatment in patients with insulin resistance.²³²⁴

This is not a reason to take metformin purely for your thyroid nodules. But if you already have prediabetes or type 2 diabetes and are taking metformin, it may be providing a secondary benefit to your thyroid. And if you have nodules alongside metabolic issues, it is worth discussing with your doctor whether addressing the insulin resistance might help manage nodule growth.

Iodine, Selenium, and Vitamin D

Nutritional factors play a supporting role. Iodine deficiency has long been associated with goiter and nodule formation, and a recent meta-analysis confirmed that iodine deficiency moderately increases the risk of developing thyroid nodules.²⁵ A cross-sectional study found that using iodized salt was associated with a substantially lower risk of nodules.²⁶ A retrospective study from iodine-sufficient South Korea found that only about 14% of thyroid nodules increased in size during follow-up, and the authors attributed this partly to adequate iodine status in the population.²⁷

An important caveat: the evidence connects iodine deficiency to nodule formation, not to nodule shrinkage from supplementation. If you live in a developed country and eat a normal diet with iodized salt, you are probably already getting enough iodine. Megadosing iodine is not a good strategy and can actually harm your thyroid. Excessive intake did not show a consistent protective effect in the meta-analysis.²⁵ If you are concerned about iodine status, ask your doctor to check your levels rather than self-supplementing.

Selenium has shown some early promise. Two small randomized trials found that selenium supplementation led to modest decreases in thyroid nodule dimensions over several months.²⁸²⁹ These are preliminary findings from small studies, and it is far too early to recommend selenium as a treatment for thyroid nodules. But selenium is essential for thyroid function, and making sure you are not deficient is reasonable general advice.

Vitamin D deficiency has been linked to higher nodule prevalence in observational studies. Patients with thyroid nodules tend to have lower vitamin D levels than those without, and a study of centenarians found a dose-dependent relationship between lower vitamin D and higher odds of nodules.³⁰³¹ Again, these are associations, not proof that vitamin D supplementation will shrink existing nodules. But correcting a known deficiency is unlikely to hurt and may support overall thyroid health.

Natural Supplements

You will find plenty of claims online about herbs and supplements that can shrink thyroid nodules. The evidence base is thin. One small double-blind trial tested a combination of spirulina, curcumin, and Boswellia extract in 34 patients over three months and found a small but statistically significant reduction in nodule area compared with placebo.³² The shrinkage was modest, and one small trial is nowhere near enough to draw strong conclusions. It is the kind of result that justifies more research, not a change in practice. Be skeptical of supplement brands that cite this study as proof their product works.

Cruciferous Vegetables and Thyroid Nodules

A recurring concern online is whether cruciferous vegetables like broccoli, kale, and cabbage are bad for your thyroid. These vegetables contain compounds called goitrogens that can interfere with iodine uptake in the thyroid. A case-control study from New Caledonia found that heavy cruciferous vegetable consumption was associated with increased thyroid cancer risk among women who already had low iodine intake.³³ The key phrase is “low iodine intake.” If your iodine levels are adequate, eating normal amounts of cruciferous vegetables is not going to cause or worsen thyroid nodules. The combination of iodine deficiency and heavy goitrogen consumption is the concern, not vegetables on their own. Cooking also reduces the goitrogen content substantially.

When Surgery Remains Necessary

Non-surgical options have expanded dramatically, but surgery is still the right choice in certain situations. If a nodule shows signs of capsule invasion, lymph node spread, or an aggressive type of papillary thyroid cancer, ablation is not appropriate and surgery is recommended.³⁴ Very large nodules that extend behind the breastbone may also be better managed surgically, since ablation techniques become less effective and harder to perform at extreme sizes. And if a biopsy returns indeterminate or suspicious results that cannot be resolved with molecular testing, surgical removal may be the safest path to a definitive diagnosis.

For most people with confirmed benign thyroid nodules that are causing symptoms or cosmetic concerns, though, the conversation with your doctor should start with ablation options rather than jumping straight to a thyroidectomy. The field has moved quickly in the past decade, and many endocrinologists and interventional radiologists now offer these procedures as standard care.

1
Endocrine Practice. Long-Term Surveillance for Benign Thyroid Nodules
2
The Journal of Clinical Endocrinology & Metabolism. Identifying and Predicting Diverse Patterns of Benign Nodule Growth
3
Korean Journal of Radiology. Efficacy and Safety of Radiofrequency Ablation for Benign Thyroid Nodules: A Prospective Multicenter Study
4
PubMed. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients
5
ScienceDirect. Improvement in thyroid-specific quality of life following radiofrequency ablation of benign thyroid nodules: A USA study
6
PubMed. Five-Year Results of Radiofrequency and Laser Ablation of Benign Thyroid Nodules: A Multicenter Study from the Italian Minimally Invasive Treatments of the Thyroid Group
7
PubMed Central. Initial Ablation Ratio Predicts Volume Reduction and Retreatment After 5 Years From Radiofrequency Ablation of Benign Thyroid Nodules
8
PubMed Central. Current guidelines for the application of radiofrequency ablation for thyroid nodules: a narrative review
9
PubMed Central. Percutaneous laser ablation for benign and malignant thyroid diseases
10
PubMed Central. Percutaneous Ultrasound-Guided Laser Ablation of Benign Thyroid Nodules: Results of 10-Year Follow-Up in 171 Patients
11
PubMed. A study on the efficacy of microwave ablation for benign thyroid nodules and related influencing factors
12
European Journal of Radiology. Safety and efficacy of microwave ablation for benign thyroid nodules and papillary thyroid microcarcinomas: A systematic review and meta-analysis
13
PubMed Central. High-intensity focused ultrasound ablation as a treatment for benign thyroid diseases: the present and future
14
PubMed. High-intensity focused ultrasound (HIFU) therapy for benign thyroid nodules: a 3-year retrospective multicenter follow-up study
15
PubMed. High-intensity focused ultrasound (HIFU) therapy for benign thyroid nodules without anesthesia or sedation
16
PubMed Central. Efficacy of Ethanol Ablation for Benign Thyroid Cysts and Predominantly Cystic Nodules: A Systematic Review and Meta-Analysis
17
PubMed. Optimum first-line treatment technique for benign cystic thyroid nodules: ethanol ablation or radiofrequency ablation?
18
PubMed Central. A clinical practice review of percutaneous ethanol injection for thyroid nodules: state of the art for benign, cystic lesions
19
Best Practice & Research Clinical Endocrinology & Metabolism. The role of radioiodine therapy in benign nodular goitre
20
PubMed Central. Changes in the size of the thyroid in patients with benign non-toxic multinodular goiter after radioactive iodine therapy
21
The Journal of Clinical Endocrinology & Metabolism. Effects of Thyroid-Stimulating Hormone Suppression with Levothyroxine in Reducing the Volume of Solitary Thyroid Nodules and Improving Extranodular Nonpalpable Changes
22
PubMed Central. Efficacy of levothyroxine on benign thyroid nodule
23
PubMed. Role of Metformin in the Treatment of Patients with Thyroid Nodules and Insulin Resistance: A Systematic Review and Meta-Analysis
24
Frontiers in Endocrinology. Efficacy of Metformin for Benign Thyroid Nodules in Subjects With Insulin Resistance: A Systematic Review and Meta-Analysis
25
PubMed Central. The myth of iodine: A systematic review and meta-analysis on the relationship between iodine and thyroid nodule
26
PubMed Central. The Effect of Iodine Status on the Risk of Thyroid Nodules: A Cross-Sectional Study in Zhejiang, China
27
International Journal of Thyroidology. Changes of Nodular Size and Its Risk Factors in Iodine-Sufficient Area: a Retrospective Cohort Analysis of 7753 Thyroid Nodules
28
Current Drug Therapy. Effects of Selenium Supplementation on Thyroid Nodule Volume in Euthyroid Patients: A Randomized Clinical Trial
29
Iranian Journal of Diabetes and Obesity. The Effect of Oral Selenium on the Size of Thyroid Nodules in Patients with Benign Thyroid nodules: A Brief Study
30
PubMed Central. Benign nodules of the thyroid gland and 25-hydroxy-vitamin D levels in euthyroid patients
31
Experimental Gerontology. Thyroid nodules and its association with vitamin D in centenarians
32
PubMed Central. Treatment for benign thyroid nodules with a combination of natural extracts
33
PubMed Central. Role of dietary iodine and cruciferous vegetables in thyroid cancer: a countrywide case-control study in New Caledonia
34
Frontiers in Endocrinology. Update of Radiofrequency Ablation for Treating Benign and Malignant Thyroid Nodules. The Future Is Now